Company: CMND
Filing Date: 2025-11-26
Form Type: F-1
Source: 0001213900-25-115501
Chunk: 58

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-26
Form: F-1
Chunk 58
---
 September 17, 2025)                                                                                                                                        |
| 10.27 |     | Form of Securities Purchase Agreement (incorporated herein by reference to Exhibit 10.1 to the registrant’s Report on Form 6-K furnished to the SEC on November 13, 2025)                                                                                                                                         |
| 10.28 |     | Form of Pre-Funded Warrant (incorporated herein by reference to Exhibit 10.2 to the registrant’s Report on Form 6-K furnished to the SEC on November 13, 2025)                                                                                                                                                    |
| 10.29 |     | Form of Securities Purchase Agreement (incorporated herein by reference to Exhibit 10.1 to the registrant’s Report on Form 6-K furnished to the SEC on November 17, 2025)                                                                                                                                         |
| 10.30 |     | Form of Pre-Funded Warrant (incorporated herein by reference to Exhibit 10.2 to the registrant’s Report on Form 6-K furnished to the SEC on November 17, 2025)                                                                                                                                                    |
| 10.31 |     | Form of Securities Purchase Agreement (incorporated herein by reference to Exhibit 10.1 to the registrant’s Report on Form 6-K furnished to the SEC on November 19, 2025)                                                                                                                                         |
| 21.1  |     | List of Subsidiaries (included as Exhibit 8.1 to our Annual Report on Form 20-F as filed with the Securities Exchange Commission on February 3, 2023, and incorporated herein by reference).                                                                                                                      |
| 23.1* |     | Consent of Brightman Almagor Zohar & Co., a Firm in the Deloitte Global Network, independent registered public accounting firm.                                                                                                                                                                                   |
| 23.2* |     | Consent of Daniel Bloch (included in Exhibit 5.1)                                                                                                                                                                                                                                                                 |
| 24.1* |     | Power of Attorney (included in signature pages of Registration Statement)                                                                                                                                                                                                                                         |
| 107*  |     | Filing Fee Table                                                                                                                                                                                                                                                                                                  |

| * | Filed herewith. |

<div align='center'>II-7

SIGNATURES</div>

Pursuant to the requirements of the Securities
Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form